Healthcare integration has the potential to save millions of lives. But, if poorly designed, it can also quietly reverse decades of progress. The difference lies not in the concept itself, but in how it is implemented.
Across Africa, healthcare integration has become the central pillar for sector reform. For long, programmes for diseases such as HIV, tuberculosis, malaria and non-communicable disease (NCD), have operated as separate, under disease-specific structures or what health planners call "vertical" systems.
But today, many countries are folding these systems and consolidating these structures into shared platforms, with a goal of achieving efficiency and Universal Health Coverage (UHC).
On paper, the case seems compelling. Integrated services promise to break service silos, make better use of limited resources, and deliver more patient-centred care rather than treating diseases.
This is why governments, donors and development partners are increasingly presenting healthcare integration as the pathway to shift from fragmented systems to strong, more resilient health systems that are capable of delivering coordinated and sustainable health care.
But, the reality of the matter is never straightforward because science is telling a more complicated story.
The most influential work on this question is a 2010 review by Rifat Atun and colleagues, which dug deeper into years of health systems records and reached a simple but important conclusion: The old "vertical versus horizontal" debate is a false choice.
In practice, integration only exists in a spectrum. But what determines its strengths or weaknesses in a health system isn't whether a programme integrates, but how and under what conditions it integrates.
Looking across different disease programmes and one clear consistent pattern emerges, integration works best when it is deliberate, adequately resourced and tailored to the unique needs of specific diseases, not when it is treated as an end in itself.
TB and HIV provide one of the strongest test cases. Because the diseases are closely linked, integrating services appears an obvious win. Studies from rural settings in Uganda and South Africa have shown that integrated TB/HIV care can reduce deaths during TB treatment, even in health facilities where treatment completion remains inconsistent. Yet the picture becomes more complex when tested under more rigorous conditions.
A randomised trial published in eClinicalMedicine found that improvements in TB and HIV integration did not consistently translate into lower mortality. These findings corroborated earlier trials concluding that integration increased diagnosis and treatment coverage, but those gains did not necessarily translate to fewer deaths.
But challenges facing integration of healthcare transcends beyond the numbers associated with its impact. Facility surveys conducted across three African nations shows there are challenges in translating policies to practice, further suggesting a need ensure that adoption of integration policies runs along integrated care services at the facility level.
Another gap that integrated healthcare faces is proper funding system. While a study on integrated community case management found that equipping community health workers in South Sudan, Uganda and Zambia to diagnose and treat malaria, pneumonia and diarrhoea through a single service platform contributed to significant reductions of children dying from malaria, around 60 percent of community health worker programmes highly depended on disease-specific donor funding, meaning, while services are integrated at the delivery point, the funding that supports the programmes remains fragmented.
 Also, financial realities are further reshaping the integration agenda. The 2025 freeze of PEPFAR funding and changes to Global Fund transition timelines have accelerated the push towards integrated healthcare, mainly driven by shrinking donor support rather than long-term health system strategy.
History offers a useful reminder. World Health Organisation (WHO) reports show that smallpox was eradicated not by dissolving disease-specific systems into general healthcare, but through exceptional surveillance, protected financing and dedicated infrastructure.
These case studies illustrate a clear pattern: Integration works when it preserves disease-specific measurement, have dedicated expertise and when critical disease-specific functions remain protected. And when integration weakens those strengths, progress slows, regardless of how promising the policies are.
Evidence from TB, NCDs, malaria, and HIV demonstrate that integration succeeds not because services are combined, but because certain conditions are deliberately protected. When those conditions are absent, integration can quietly weaken the very health systems it aims to strengthen.
First step to integration is to preserve disease-specific data. Beyond tracking process indicators, health systems must continue to monitor disease-specific outcomes, mortality, viral suppression, treatment completion, and other measures that reveal whether people are actually getting better.
Second, finance integration as a system, not a project. Lasting integration requires sustainable domestic financing and funding mechanisms that reinforce, rather than undermine integrated care. Good intentions alone cannot compensate for fragile funding.
Third, protect specialised expertise. Preserving a specific skills, clinical leadership, and disease-specific technical capacity is essential if quality of care is to improve.
Fourth, safeguard the pathways that vulnerable populations rely on. Integration implemented without adequate staffing, training, or privacy protections risks recreating the very barriers that vertical programmes were designed to overcome. Equity must be built into integration from the outset, not treated as an afterthought.
The real test is design, not willpower.
Integration will shape the next chapter of health reform across Africa and evidence shows this is achievable.
But the greatest danger is not that integration will fail outright. It is that it will move faster than the evidence guiding it, gradually exchanging measurable disease control for diffuse priorities within already stretched health systems.
Ultimately, integration should be judged not by how services are organised, but by whether more people live longer, healthier lives because of it.
